2021
Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
GREGOROVÁ, Jana, Petra VYCHYTILOVÁ a Sabina ŠEVČÍKOVÁZákladní údaje
Originální název
Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
Autoři
GREGOROVÁ, Jana (203 Česká republika, domácí), Petra VYCHYTILOVÁ (203 Česká republika, domácí) a Sabina ŠEVČÍKOVÁ (203 Česká republika, garant, domácí)
Vydání
Cancers, Basel, MDPI, 2021, 2072-6694
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 6.575
Kód RIV
RIV/00216224:14110/21:00121359
Organizační jednotka
Lékařská fakulta
UT WoS
000634331300001
Klíčová slova anglicky
microRNA clusters; microRNA families; epigenetics; tumor development; DNA methylation; histone modifications; epigenetic therapy
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 7. 6. 2021 13:37, Mgr. Tereza Miškechová
Anotace
V originále
MicroRNAs are small non-coding single-stranded RNA molecules regulating gene expression on a post-transcriptional level based on the seed sequence similarity. They are frequently clustered; thus, they are either simultaneously transcribed into a single polycistronic transcript or they may be transcribed independently. Importantly, microRNA families that contain the same seed region and thus target related signaling proteins, may be localized in one or more clusters, which are in a close relationship. MicroRNAs are involved in basic physiological processes, and their deregulation is associated with the origin of various pathologies, including solid tumors or hematologic malignancies. Recently, the interplay between the expression of microRNA clusters and families and epigenetic machinery was described, indicating aberrant DNA methylation or histone modifications as major mechanisms responsible for microRNA deregulation during cancerogenesis. In this review, the most studied microRNA clusters and families affected by hyper- or hypomethylation as well as by histone modifications are presented with the focus on particular mechanisms. Finally, the diagnostic and prognostic potential of microRNA clusters and families is discussed together with technologies currently used for epigenetic-based cancer therapies.